ArticleJAMA network open2026
Estimation of Mortality via the Neighborhood Atlas and Reproducible Area Deprivation Indices.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Are we measuring neighborhood disadvantage wrong? A methodological reassessment of its structure in the United States.SSM - population health · 2026Article
- Assessing the Relationship Between Multidimensional Area-Level Indicators and Lupus Disease Activity in Children.Children (Basel, Switzerland) · 2026Article
- Rural-urban comparisons of area-based socioeconomic disadvantage and vulnerability indices.Health affairs scholar · 2026Article
- Validity of Area-Based Social Risk Indices Used at Higher-Level Geographies and Clinic Locations.JAMA network open · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Importance: The Neighborhood Atlas Area Deprivation Index (NA-ADI) has been widely used in health policy research and incorporated into Medicare payment models such as the Accountable Care Organization Realizing Equity, Access, and Community Health model. However, calculation errors have been independently identified by multiple groups, showing that the NA-ADI contains distorted deprivation estimates that pose risks to equitable funding allocation and outcome adjustment. Objective: To develop the Reproducible ADI (ReADI) as a corrected, transparent replacement aligned with the original ADI methodology and to compare its agreement with established deprivation indices, including the Social Vulnerability Index (SVI), Social Deprivation Index, French Deprivation Index, and Neighborhood Stress Score, and its performance for estimating mortality. Design, Setting, and Participants: This cross-sectional study used 2011-2015 and 2018-2022 data from the American Community Survey (ACS), a population-based US sample across census block groups, tracts, and counties. US geographic levels with sufficient data included 235 952 block groups, 83 722 census tracts, and 3214 counties. Census tract-level 2011-2015 mortality data were obtained from the US Small-Area Life Expectancy Estimates Project. Data from the 2015 NA-ADI were accessed March 7, 2024, and data from the 2022 NA-ADI, December 1, 2024. Exposures: The ReADI was constructed using corrected methods described in the original work developing the ADI. The NA-ADI was downloaded and aggregated to tract and county levels. The SVI was from the Centers for Disease Control and Prevention. Other indices were independently constructed from the ACS. Main Outcomes and Measures: The primary outcomes were ReADI and NA-ADI comparisons against each other, other deprivation indices, and mortality. Results: The ReADI more closely aligned with other deprivation indices (R2 range, 0.609 [95% CI, 0.586-0.630] to 0.932 [95% CI, 0.931-0.933]) compared with the NA-ADI (R2 range, 0.331 [95% CI, 0.300-0.362] to 0.710 [95% CI, 0.692-0.727]). ReADI scores also better reflected component weights (R2 ≥ 0.999 [95% CI, 0.996-1.000]; RMSE ≤ 0.042 [95% CI, 0.029-0.053]) compared with the NA-ADI (R2 range, 0.832 [95% CI, 0.574-0.932] to 0.844 [95% CI, 0.601-0.937]; RMSE range, 0.346 [95% CI, 0.279-0.414] to 0.405 [95% CI, 0.334-0.470]), consistent with correct computation. In 3332 high-discrepancy census tracts representing approximately 13 million individuals, the ReADI explained more variance in life expectancy (R2 difference, 0.064; 95% CI, 0.039-0.090), particularly in underresourced urban areas. Conclusions and Relevance: In this cross-sectional study, the ReADI was correctly calculated and should replace the flawed NA-ADI for future health policy applications. Its open-source methods support transparency, adaptability, and further development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.